Procedure
Sleep Disturbance + Study Drug for Sleep Disorders
This trial tests how different types of sleep problems affect the brain's response to a pain-relief drug and its potential for abuse. Healthy subjects will have their sleep patterns manipulated and then undergo brain scans and pain tests. The goal is to see if poor sleep makes pain drugs less effective or more likely to be abused.
Behavioral Intervention
Sign Language Instruction for Deafness
This trial will involve teachers who will be split into two groups - one group will receive training to help deaf children learn sign language, while the other group will continue with their usual teaching methods. The study will assess the progress of deaf children at the beginning and end of the school year.
Tobacco Regulations for Smoking
This trial aims to investigate the impact of proposed tobacco regulations in rural Appalachian Kentucky. The study will focus on three specific regulations and how they affect tobacco users in this area. Participants will take surveys, participate
Popular Filters
Trials With No Placebo
Gene Therapy
Gene Therapy for Duchenne Muscular Dystrophy
This trial is testing a new gene therapy called fordadistrogene movaparvovec. It aims to see if the therapy is safe and effective over a long period. The treatment works by fixing or replacing problematic genes in the body.
Procedure
ROSI for Male Infertility
This trial is testing a procedure that uses immature sperm cells to help men who can't produce mature sperm have biological children. The process involves selecting these cells and injecting them into an egg, with extra steps to ensure the egg is ready to develop. This technique has been explored as an alternative for men who cannot produce mature sperm.
FAPi & PSMA PET/CT Imaging for Cancer Detection
This trial is using a new imaging technique, FAPi PET/CT, to study how well it can detect cancer in patients with non-prostate cancer. The team is also interested in using another new imaging technique, PSMA PET/CT. Patients will have PET/CT scans with either the FAPI or PSMA tracer. This trial is to see if these new techniques are effective in detecting cancer.
Frequently Asked Questions
Introduction to experimental
What are the top hospitals conducting experimental research?
In the realm of medical advancements, clinical trials for experimental treatments hold tremendous promise. Among the leading hospitals conducting such trials, Seattle Cancer Care Alliance in Seattle shines as a beacon of hope. Currently engaged in three active experimental trials, this institution is dedicated to exploring innovative approaches and pushing boundaries in cancer treatment. Beth Israel Deaconess Medical Center in Boston also embraces the spirit of discovery with two ongoing experimental trials that are contributing to cutting-edge research efforts. Meanwhile, Oregon Health & Science University in Portland stands at the forefront of medical innovation by actively participating in two experimental trials aimed at uncovering novel therapies. Joining these prestigious institutions is Massachusetts General Hospital, another renowned medical center where researchers are diligently working on two active experimental trials to push forward frontiers previously unexplored.
In New york City's Mount Sinai Hospital, scientists and physicians are blazing new trails through their involvement in two current experimental trials. By continually seeking out uncharted territories and delving into unconventional ideas within the field of medicine, these top hospitals embody a relentless pursuit of better treatment options for patients.
Although each hospital may have no recorded past experiments yet due to their focus on emerging methodologies or unique investigations; it is precisely this pioneering spirit that drives them towards future breakthroughs - placing them at the forefront of healthcare innovation and nurturing optimism for countless individuals seeking alternative paths towards improved health outcomes
Which are the best cities for experimental clinical trials?
When it comes to experimental clinical trials, several cities offer promising opportunities for participation. New york, New York stands out with 10 active trials exploring treatments like TRV027, fluorouracil, and Pembrolizumab. Seattle, Washington follows closely behind with 9 ongoing studies focusing on BMS-986165, Pembrolizumab, and fluorouracil interventions. Additionally, Chicago, Illinois showcases 8 active trials investigating potential breakthroughs such as Experiment 1 and Oral Micronized Progesterone 200mg. These cities are joined by Boston, Massachusetts which offers 7 active trials studying treatments including fluorouracil and Interferon Gamma-1b. Lastly, Atlanta, Georgia provides access to 6 active trials examining innovative options like TRV027 and Treatment approaches. With their commitment to research advancements in healthcare delivery, these cities present individuals with the opportunity to contribute to pioneering medical discoveries through experimental clinical trials.
Which are the top treatments for experimental being explored in clinical trials?
The top treatments currently being explored in clinical trials for breast cancer are daratumumab, belantamab mafodotin, and lenalidomide.
- Daratumumab: This powerful drug is being tested in six active trials specifically focused on breast cancer. It has been listed since 2012 and has a total of 134 all-time breast cancer trials.
- Belantamab mafodotin: This treatment shows promise with four ongoing clinical trials dedicated to studying its efficacy against breast cancer. Since its introduction in 2018, it has already been involved in a total of 26 all-time breast cancer trials.
- Lenalidomide: A well-established player in the field, lenalidomide is currently being investigated in three active clinical trials for breast cancer. With an impressive history dating back to 2003, it has participated in a remarkable total of 280 all-time clinical trials across various indications.
These treatments offer hope and potential breakthroughs for patients battling this challenging disease as researchers continue their tireless efforts to find effective solutions through rigorous clinical investigations.
What are the most recent clinical trials for experimental?
In the realm of experimental treatments, recent clinical trials have showcased promising developments that offer new possibilities for patients. Among them is ICI-Resistant, a phase 2 trial targeted at addressing immunotherapy resistance in cancer treatment. Additionally, the INFLUENZA G1 mHA Dose Level 2 study explores the potential benefits of combining Al(OH)3 with experimental influenza therapy. A large-scale phase 3 trial called "All participants" aims to evaluate an experimental intervention across a diverse population. Another intriguing avenue being explored is bacteriophage therapy in a combined phase 1 and phase 2 study. Lastly, cohort 1 of the PF-07081532 trial seeks to unveil potential therapeutic effects as part of its early-phase research efforts. These recent clinical trials provide optimism and hold promise for advancing our understanding and treatment options within the field of experimentation.
What experimental clinical trials were recently completed?
Several experimental clinical trials have recently concluded, showcasing the progress being made in medical research. Among these notable studies are the completion of a trial sponsored by Washington University School of Medicine in October 2021, investigating Uproleselan's potential for multiple myeloma treatment. Another significant milestone was reached in September 2021 with the conclusion of a trial conducted by the National Cancer Institute (NCI) on mRNA-1273. Additionally, AgenTus Therapeutics successfully wrapped up their agenT-797 study in January 2021. These completed trials represent important steps forward as scientists strive to uncover innovative approaches to combat various diseases and improve patient outcomes.